相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273
Shyh Poh Teo
JOURNAL OF PHARMACY PRACTICE (2022)
Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle
Uday S. Kumar et al.
ACS NANO (2021)
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Mohamad-Gabriel Alameh et al.
IMMUNITY (2021)
STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33-driven type 2 immunopathology
Li She et al.
JCI INSIGHT (2021)
First COVID-19 DNA vaccine approved, others in hot pursuit
Cormac Sheridan
NATURE BIOTECHNOLOGY (2021)
Engineered drug delivery devices to address Global Health challenges
Ilin Sadeghi et al.
JOURNAL OF CONTROLLED RELEASE (2021)
DNA vaccines against COVID-19: Perspectives and challenges
Marcelle Moura Silveira et al.
LIFE SCIENCES (2021)
An Update on Self-Amplifying mRNA Vaccine Development
Anna K. Blakney et al.
VACCINES (2021)
Niosomes formation using a continuous supercritical CO2 assisted process
Lucia Baldino et al.
JOURNAL OF CO2 UTILIZATION (2021)
WHAT SCIENTISTS DO AND DON'T KNOW ABOUT THE OXFORD-ASTRAZENECA COVID VACCINE
Heidi Ledford et al.
NATURE (2021)
INDIA'S DNA COVID VACCINE IS A WORLD FIRST - MORE ARE COMING
Smriti Mallapaty
NATURE (2021)
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine
Qin Li et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory
Ole A. W. Haabeth et al.
ACS CENTRAL SCIENCE (2021)
In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment
Shan Guan et al.
PHARMACEUTICS (2021)
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs
Melissa P. Lokugamage et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
Pablo Tebas et al.
ECLINICALMEDICINE (2021)
Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV
Kevin E. Lindsay et al.
MOLECULAR THERAPY (2020)
Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Ji Wang et al.
SCIENCE (2020)
Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
Michael Lim et al.
PHARMACEUTICS (2020)
The Effects of Secretory IgA in the Mucosal Immune System
Yue Li et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
Leticia Moreno-Fierros et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice
Xinyu Zhuang et al.
VACCINES (2020)
Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity
Yaping Mai et al.
CELLULAR IMMUNOLOGY (2020)
Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects
Saliha Durak et al.
NANOMATERIALS (2020)
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O. Hassan et al.
CELL (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice
Andrea N. Loes et al.
VIRUSES-BASEL (2020)
Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial
Vesa Anttila et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
Katlyn Lederer et al.
IMMUNITY (2020)
A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Intranasally administered protein coated chitosan nanoparticles encapsulating influenza H9N2 HA2 and M2e mRNA molecules elicit protective immunity against avian influenza viruses in chickens
Irshad Ahmed Hajam et al.
VETERINARY RESEARCH (2020)
Self-assembled peptide-poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis
Shan Guan et al.
NATURE NANOTECHNOLOGY (2019)
Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery
Santiago Grijalvo et al.
PHARMACEUTICS (2019)
Friend or Foe: The Protective and Pathological Roles of Inducible Bronchus-Associated Lymphoid Tissue in Pulmonary Diseases
Nancy D. Marin et al.
JOURNAL OF IMMUNOLOGY (2019)
Mucosal vaccines and technology
A. Miquel-Clopes et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to M. Tuberculosis Infection
Antonella Riccomi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Intrapulmonary Cellular-Level Distribution of Inhaled Nanoparticles with Defined Functional Groups and Its Correlations with Protein Corona and Inflammatory Response
Bohan Yin et al.
ACS NANO (2019)
Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide
Yingshan Qiu et al.
JOURNAL OF CONTROLLED RELEASE (2019)
A Liposome-Based Adjuvant Containing Two Delivery Systems with the Ability to Induce Mucosal Immunoglobulin A Following a Parenteral Immunization
Dennis Christensen et al.
ACS NANO (2019)
Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
Asha Kumari Patel et al.
ADVANCED MATERIALS (2019)
Nasal route for vaccine and drug delivery: Features and current opportunities
Yadira Lobaina Mato
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Ema Robinson et al.
MOLECULAR THERAPY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
A revised airway epithelial hierarchy includes CFTR-expressing ionocytes
Daniel T. Montoro et al.
NATURE (2018)
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
Pooja Munnilal Tiwari et al.
NATURE COMMUNICATIONS (2018)
Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults
Daniel F. Hoft et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+T cells in the lung
K. M. Morabito et al.
MUCOSAL IMMUNOLOGY (2017)
Mechanism of action of mRNA-based vaccines
Carlo Iavarone et al.
EXPERT REVIEW OF VACCINES (2017)
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
S. Guan et al.
GENE THERAPY (2017)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Martin Alberer et al.
LANCET (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge
Manli Wu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Tools for translation: non-viral materials for therapeutic mRNA delivery
Khalid A. Hajj et al.
NATURE REVIEWS MATERIALS (2017)
Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses
Man Li et al.
ACTA BIOMATERIALIA (2017)
Polymer-drug conjugates as inhalable drug delivery systems: A review
Nirmal Marasini et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2017)
Pulmonary immunity to viruses
S. Rameeza Allie et al.
CLINICAL SCIENCE (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
Early local immune defences in the respiratory tract
Akiko Iwasaki et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Jeffrey M. Jacobson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Mucosal vaccine delivery: Current state and a pediatric perspective
Akhilesh Kumar Shakya et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
Man Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
Hok Hei Tam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition
Simon Sebastian Raesch et al.
ACS NANO (2015)
Effect of vaccine administration modality on immunogenicity and efficacy
Lu Zhang et al.
EXPERT REVIEW OF VACCINES (2015)
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Norbert Pardi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
Andreas Thess et al.
MOLECULAR THERAPY (2015)
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity
Natalie L. Trevaskis et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration
Sarah M. Johler et al.
PLOS ONE (2015)
Dynamics of B cells in germinal centres
Nilushi S. De Silva et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Current progress in pulmonary delivery of measles vaccine
Diane E. Griffin
EXPERT REVIEW OF VACCINES (2014)
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
Luis A. Brito et al.
MOLECULAR THERAPY (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
Kyle K. L. Phua et al.
SCIENTIFIC REPORTS (2014)
Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo
Kenneth C. McCullough et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Mucosal resident memory CD4 T cells in protection and immunopathology
Damian Lanz Turner et al.
FRONTIERS IN IMMUNOLOGY (2014)
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives
Yingying Xu et al.
Pharmaceutics (2014)
Size-Dependent Uptake of Particles by Pulmonary Antigen-Presenting Cell Populations and Trafficking to Regional Lymph Nodes
Fabian Blank et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection
Jamie F. S. Mann et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Airway CD8+ T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity
M. Bivas-Benita et al.
MUCOSAL IMMUNOLOGY (2013)
Dendritic Cells Are the Major Antigen Presenting Cells in Inflammatory Lesions of Murine Mycoplasma Respiratory Disease
Xiangle Sun et al.
PLOS ONE (2013)
Vaccine adjuvant formulations: A pharmaceutical perspective
Luis A. Brito et al.
SEMINARS IN IMMUNOLOGY (2013)
Biomedical applications of amino acid-modified chitosans: A review
Luca Casettari et al.
BIOMATERIALS (2012)
Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients
Erik H. J. G. Aarntzen et al.
CLINICAL CANCER RESEARCH (2012)
Novel vaccine development strategies for inducing mucosal immunity
Yoshiko Fujkuyama et al.
EXPERT REVIEW OF VACCINES (2012)
Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein
Dharmendra Raghuwanshi et al.
MOLECULAR PHARMACEUTICS (2012)
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
Frank Wegmann et al.
NATURE BIOTECHNOLOGY (2012)
Biomolecular coronas provide the biological identity of nanosized materials
Marco P. Monopoli et al.
NATURE NANOTECHNOLOGY (2012)
Mucosal IgA responses in influenza virus infections; thoughts for vaccine design
Elly van Riet et al.
VACCINE (2012)
The mucosal immune system of the respiratory tract
Shintaro Sato et al.
CURRENT OPINION IN VIROLOGY (2012)
Particulate vaccines: on the quest for optimal delivery and immune response
Marie-Luce De Temmerman et al.
DRUG DISCOVERY TODAY (2011)
Macrophages and dendritic cells express tight junction proteins and exchange particles in an in vitro model of the human airway wall
Fabian Blank et al.
IMMUNOBIOLOGY (2011)
Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection
John R. Teijaro et al.
JOURNAL OF IMMUNOLOGY (2011)
Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses
Lea Torrieri-Dramard et al.
MOLECULAR THERAPY (2011)
Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity
F-E Johansen et al.
MUCOSAL IMMUNOLOGY (2011)
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Katalin Kariko et al.
NUCLEIC ACIDS RESEARCH (2011)
Intranasal Delivery of Cationic PLGA Nano/Microparticles- Loaded FMDV DNA Vaccine Encoding IL-6 Elicited Protective Immunity against FMDV Challenge
Gang Wang et al.
PLOS ONE (2011)
Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis
Julio C. C. Lorenzi et al.
BMC BIOTECHNOLOGY (2010)
Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
Byoung-Shik Shim et al.
BMC IMMUNOLOGY (2010)
DNA vaccines for targeting bacterial infections
Mariana Ingolotti et al.
EXPERT REVIEW OF VACCINES (2010)
An overview of liposome lyophilization and its future potential
Chengjun Chen et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Enhancement of Transdermal Absorption, Gene Expression and Stability of Tyrosinase Plasmid (pMEL34)-Loaded Elastic Cationic Niosomes: Potential Application in Vitiligo Treatment
Jiradej Manosroi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Efficient Generation of Mucosal and Systemic Antigen-Specific CD8+ T-Cell Responses following Pulmonary DNA Immunization
Maytal Bivas-Benita et al.
JOURNAL OF VIROLOGY (2010)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
Larry R. Smith et al.
VACCINE (2010)
Application of chitosan microspheres for nasal delivery of vaccines
Mi Lan Kang et al.
BIOTECHNOLOGY ADVANCES (2009)
DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
Lindsey Low et al.
HUMAN GENE THERAPY (2009)
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Distinct Profiles of Cytotoxic Granules in Memory CD8 T Cells Correlate with Function, Differentiation Stage, and Antigen Exposure
Alexandre Harari et al.
JOURNAL OF VIROLOGY (2009)
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
Scott G. Hansen et al.
NATURE MEDICINE (2009)
Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory Viruses
James A. Wiley et al.
PLOS ONE (2009)
Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone®) increases antibody response, cellular immunity, and antigenically drifted protection
Marla Lay et al.
VACCINE (2009)
Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas
Kenji Mishima
ADVANCED DRUG DELIVERY REVIEWS (2008)
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes
Rogerio S. Rosada et al.
BMC IMMUNOLOGY (2008)
T cell responses to whole SARS coronavirus in humans
Chris Ka-fai Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Katalin Kariko et al.
MOLECULAR THERAPY (2008)
DNA vaccines: ready for prime time?
Michele A. Kutzler et al.
NATURE REVIEWS GENETICS (2008)
Tight junction-based epithelial microenvironment and cell proliferation
S. Tsukita et al.
ONCOGENE (2008)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Surface modified liposomes for nasal delivery of DNA vaccine
Kapil Khatri et al.
VACCINE (2008)
DNA vaccines: precision tools for activating effective immunity against cancer
Jason Rice et al.
NATURE REVIEWS CANCER (2008)
In vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide-mediated process
Udaya Sankar Kadimi et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Nanoparticles and microparticles as vaccine-delivery systems
Manmohan Singh et al.
EXPERT REVIEW OF VACCINES (2007)
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: Effect of the formulation parameters on complexation and transfection of antisense oligonucleotides
Noha Nafee et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
A silent polymorphism in the MDR1 gene changes substrate specificity
Chava Kimchi-Sarfaty et al.
SCIENCE (2007)
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Silke Holtkamp et al.
BLOOD (2006)
Apoptosis in activated T cells -: What are the triggers, and what the signal transducers?
Georg Haecker et al.
CELL CYCLE (2006)
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming
Rhys S. Allan et al.
IMMUNITY (2006)
mRNA transfection of dendritic cells:: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level
M Mockey et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A major lung CD103 (αE)-β7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins
SSJ Sung et al.
JOURNAL OF IMMUNOLOGY (2006)
Adverse events reported following live, cold-adapted, intranasal influenza vaccine
HS Izurieta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection
BO Lee et al.
JOURNAL OF IMMUNOLOGY (2005)
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against Hepatitis B
S Jain et al.
IMMUNOLOGY LETTERS (2005)
Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract
C von Garnier et al.
JOURNAL OF IMMUNOLOGY (2005)
The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces
CS Kaetzel
IMMUNOLOGICAL REVIEWS (2005)
Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA
K Karikó et al.
IMMUNITY (2005)
Differential contributions of central and effector memory T cells to recall responses
AD Roberts et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination
CG Oster et al.
JOURNAL OF CONTROLLED RELEASE (2005)
T cell vaccines for microbial infections
HL Robinson et al.
NATURE MEDICINE (2005)
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
MNVR Kumar et al.
BIOMATERIALS (2004)
Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis
M Bivas-Benita et al.
VACCINE (2004)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
M Mutsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase
YL Lo et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity
JE Moyron-Quiroz et al.
NATURE MEDICINE (2004)
Nalt- versus Peyer's-patch-mediated mucosal immunity
H Kiyono et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
T Fifis et al.
JOURNAL OF IMMUNOLOGY (2004)
Messenger RNA-based vaccines
S Pascolo
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection
CW Lawrence et al.
JOURNAL OF IMMUNOLOGY (2004)
Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses
DQ Wang et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium
M Bivas-Benita et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route
Y Perrie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1
S Gogev et al.
VACCINE (2004)
Thiolated chitosans
A Bernkop-Schnurch et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination
ST Rottinghaus et al.
VACCINE (2003)
Constitutive display of cryptic translation products by MHC class I molecules
SR Schwab et al.
SCIENCE (2003)
PEI -: a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice
K Regnström et al.
GENE THERAPY (2003)
Membranous cells in nasal-associated lymphoid tissue: A portal of entry for the respiratory mucosal pathogen group A streptococcus
HS Park et al.
JOURNAL OF IMMUNOLOGY (2003)
Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice
M Iqbal et al.
VACCINE (2003)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
J Panyam et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
CD4 effector T cell subsets in the response to influenza:: Heterogeneity, migration, and function
E Román et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques
SE Beck et al.
MOLECULAR THERAPY (2002)
Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection
M Kumar et al.
HUMAN GENE THERAPY (2002)
Improved tuberculosis DNA vaccines by formulation in cationic lipids
S D'Souza et al.
INFECTION AND IMMUNITY (2002)
Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses
AW Zuercher et al.
JOURNAL OF IMMUNOLOGY (2002)
+1 frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10
X Saulquin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L Thiele et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Protection from respiratory virus infections can be mediated by antigen-specific CD4+ T cells that persist in the lungs
RJ Hogan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Polysaccharide colloidal particles as delivery systems for macromolecules
KA Janes et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
DNA vaccination against respiratory influenza virus infection
JP Wong et al.
VACCINE (2001)
Immune stimulating activity of two new chitosan containing adjuvant formulations
PG Seferian et al.
VACCINE (2000)
Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery
A Gautam et al.
MOLECULAR THERAPY (2000)
Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes
JC Birchall et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization
CL Densmore et al.
MOLECULAR THERAPY (2000)
分享论文
